INNOVATIVE DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

Biopharmaceutical / Biotechnology Innovator

We are a disruptive emerging biopharmaceutical/biotechnology innovator, challenging the status quo by shifting traditional medical paradigms. We are pushing boundaries and driving innovation by turning groundbreaking science into cutting-edge diagnostics and therapeutics.

BIOSYNC TECHNOLOGY

Our BioSync™ Platform

The BioSyncTM Platform has been designed as the first and only platform that integrates agribiopharmaceuticals with biopharmaceuticals and biotechnology.

This advanced data procurement creates a world-class, robust, and innovative data management platform.

Research Initiatives

Vyripharm Enterprises, Inc. and Colorado State University-Pueblo Announce Sponsored Research and Facilities Agreement.

Vyripharm International, Inc. and the National Yang-Ming University Signed a MOU to Develop VYR-206 as a Novel Diagnostic Approach for Neurological Disorders Outcomes Following Treatments.

Vyripharm biopharmaceuticals and Regis Technologies, Inc. Have Signed Off on a Master Drug Program Agreement for Expediting cGMP Manufacture of Our Antiviral Agents for Diagnostic Evaluation of COVID-19.

Vyripharm biopharmaceuticals Is in the Development Stage of a Novel Integrated Theranostic Approach for the Treatment of Viral Infections Such as COVID-19.

Vyripharm Enterprises, Inc. is headquartered in the world-renowned Texas Medical Center located in Houston, Texas.

Drag View

VYRIPHARM IS COMMITTED TO:

Helping People Live Better Lives

Quality Assurance and Quality Control is Vyripharm’s focus for enhancing public safety, public health and public awareness.